Tetrabutylammonium Fluoride → HCID 18932737, compound
Reaction equation
[CH3:1][O:2][C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][C:12]=1[O:13][CH3:14])[N:9]=[CH:8][N:7]=[C:6]2[N:15]1[C:23]2[C:18](=[CH:19][CH:20]=[C:21]([C:24]#[C:25][Si](C)(C)C)[CH:22]=2)[CH2:17][CH2:16]1.[F-].C([N+](CCCC)(CCCC)CCCC)CCC>CO.C1COCC1>[C:24]([C:21]1[CH:22]=[C:23]2[C:18]([CH2:17][CH2:16][N:15]2[C:6]2[C:5]3[C:10](=[CH:11][C:12]([O:13][CH3:14])=[C:3]([O:2][CH3:1])[CH:4]=3)[N:9]=[CH:8][N:7]=2)=[CH:19][CH:20]=1)#[CH:25]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To 6,7-dimethoxy-4-(6-trimethylsilanylethynyl-2,3-dihydro-indol-1-yl)-quinazoline (1 eq.; 50 mg; 0.124 mmol) in MeOH (2 mL)/THF (2 mL) was treated with 1M tetrabutylammonium fluoride (2 eq.; 0.248 mL) in THF at 20° C. for 16 hours. Solvents were removed in vacuo and the residue was dissolved in 1:1 EtOAc/Et2O washed with saturated aqueous NaHCO3, dried over Na2SO4(s), filtered and concentrated in vacuo. The product was converted to the HCl salt using a procedure analogous to that described for Example 2. (M.P. 241°-243° C.; LC-MS: 332 (MH+); RP18-HPLC RT: 4.48 min)
Workup
- customSolvents were removed in vacuo
- dissolutionthe residue was dissolved in 1:1 EtOAc/Et2O
- washwashed with saturated aqueous NaHCO3
- dry with materialdried over Na2SO4(s)
- filtrationfiltered
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-862c151e61a64192867c1589ec3e5022
- Source dataset
- uspto-grants-1998_04
- Patent number
- US05736534
Reaction notes
Loading…